Sign in
4

Changes in Ownership

ORTHOPEDIATRICS CORP Filed Acc 0001425450-20-000047

President and CEO sold 1,876 shares at an average $46.56 ($87,351)

  • President and CEO acquired 1,876 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Throdahl Mark C · President and CEO

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2020-05-20 Exercise or conversion : show line 1 in the form +670 $30.97 $20,750 155,616 D
2020-05-20 Exercise or conversion : show line 2 in the form +402 $30.97 $12,450 156,018 D
2020-05-20 Exercise or conversion : show line 3 in the form +402 $30.97 $12,450 156,420 D
2020-05-20 Exercise or conversion : show line 4 in the form +402 $30.97 $12,450 156,822 D
2020-05-20 Sale : show line 5 in the form −670 $46.56 $31,195 156,152 D
2020-05-20 Sale : show line 6 in the form −402 $46.56 $18,717 155,750 D
2020-05-20 Sale : show line 7 in the form −402 $46.56 $18,717 155,348 D
2020-05-20 Sale : show line 8 in the form −402 $46.57 $18,721 154,946 D
Open-market sales · 1,876 sh · avg $46.56 · $87,351

Table II: Derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-05-20 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −670 $30.97 $20,750 0 D
2020-05-20 Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) −402 $30.97 $12,450 0 D
2020-05-20 Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) −402 $30.97 $12,450 0 D
2020-05-20 Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) −402 $30.97 $12,450 0 D
Loading xslF345X03/wf-form4_159009283321781.xml…